Janssen Sciences Ireland UC
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- PARIET gastro-resistant tablet 10 mg
- PARIET gastro-resistant tablet 20 mg
- D01 - Antifúngicos para uso dermatológico
- DAKTACORT cream 2%+1%
- G01 - Antiinfecciosos y antisépticos ginecológicos
- GYNO-DAKTARIN vaginal cream 2%
- G04 - Urológicos
- LYRINEL XL prolonged-release tablet 10 mg
- LYRINEL XL prolonged-release tablet 5 mg
- J02 - Antimicóticos de uso sistémico
- SPORANOX capsule, hard 100 mg
- SPORANOX concentrate for solution for infusion 10 mg/ml
- SPORANOX oral solution 10 mg/ml
- N02 - Analgésicos
- DUROGESIC transdermal patch 100 µg/h
- DUROGESIC transdermal patch 12 µg/h
- DUROGESIC transdermal patch 25 µg/h
- DUROGESIC transdermal patch 50 µg/h
- DUROGESIC transdermal patch 75 µg/h
- N03 - Antiepilépticos
- TOPAMAX film-coated tablet 100 mg
- TOPAMAX film-coated tablet 200 mg
- TOPAMAX film-coated tablet 25 mg
- TOPAMAX film-coated tablet 50 mg
- TOPAMAX SPRINKLE capsule, hard 15 mg
- TOPAMAX SPRINKLE capsule, hard 25 mg
- N05 - Psicolépticos
- HALDOL DECANOAS solution for injection 50 mg/1 ml
- HALDOL DECANOATE solution for injection 100 mg/1 ml
- RISPERDAL CONSTA powder and solvent for suspension for injection 25 mg
- RISPERDAL CONSTA powder and solvent for suspension for injection 37.5 mg
- RISPERDAL CONSTA powder and solvent for suspension for injection 50 mg
- RISPERDAL film-coated tablet 0.5 mg
- RISPERDAL film-coated tablet 1 mg
- RISPERDAL film-coated tablet 2 mg
- RISPERDAL film-coated tablet 3 mg
- RISPERDAL film-coated tablet 4 mg
- RISPERDAL film-coated tablet 6 mg
- RISPERDAL oral solution 1 mg/ml
- N06 - Psicoanalépticos
- CONCERTA XL prolonged-release tablet 18 mg
- CONCERTA XL prolonged-release tablet 27 mg
- CONCERTA XL prolonged-release tablet 36 mg
- N07 - Otros fármacos activos sobre el sistema nervioso
- SIBELIUM tablet 5 mg